Press Release Title Background

Positron Emission Tomography Devices Market to Grow at a CAGR of 7.19% During 2025 to 2035; Driven by Increasing Demand for Advanced Diagnostic Imaging Technologies

Report Details:
15 Companies Covered
200 Pages

Positron Emission Tomography Devices Market Highlights


The Positron Emission Tomography Devices Market Size was estimated at 3.96 USD Billion in 2024. The Positron Emission Tomography Devices industry is projected to grow from 4.245 USD Billion in 2025 to 8.499 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.19% during the forecast period 2025 - 2035


Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market. According to the 2024 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.


Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market.


However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.


Segmentation


The global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.


The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.


The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others


Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others.


Regional Analysis


The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.


Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.


On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.


Key Players



  • Technological advancements are enhancing the capabilities of PET devices, leading to improved diagnostic accuracy.

  • North America remains the largest market for PET devices, while the Asia-Pacific region is emerging as the fastest-growing market.

  • PET/CT systems dominate the market, whereas integrated PET systems are witnessing rapid growth due to their advanced features.

  • Key market drivers include the rising incidence of cancer and the growing geriatric population, which are fueling demand for advanced imaging solutions.